Jun 2026 (Q2 FY26) — Jul 31, 2026
CNO Financial Group Q2 FY26 — Strong Earnings and Sales Growth, Raised FY26 EPS Guidance
Read the full callCNO Financial Group (CNO) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
CNO Financial Group earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,285 | +11.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.8 | +2.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 126 | +37.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
10 of 11 judged targets kept · 17 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Exit of the Worksite fee services business | substantially complete in the first half of 2026 | Sep 2025 | Ghosted | |
| Full-year effective tax rate | approximately 22.5% | Dec 2025 | we are lowering our effective tax rate assumption to approximately 21.5% | Revised Up |
| Medicare Supplement rate filings effective 1 January 2026 | average requested rate increase in the 10% range | Jun 2025 | the closed block with a January 1, '26 effective date asking for an increase of 10.5%, and we received approvals for 10.2% | Achieved |
1 of CNO Financial Group, Inc.'s 28 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 25 more targets are in the full ledger.
Claimed
- Operating earnings per diluted share up 45% in Q2 and 43% year-to-date, excluding significant items.
- 16th consecutive quarter of sales growth and 14th consecutive quarter of producing agent count growth.
- Full year operating EPS guidance raised to a range of $4.60 to $4.80, an 8% increase at the midpoint.
- Total new annualized premiums (NAP) up 7%, with multiple sales records set.
- Annuity collected premiums reached a new record of $536 million, up 3%, and client assets up 24% to a new record.
Qualified
- Consumer Life NAP was down 9% for the quarter against a strong comparable, primarily driven by lower direct-to-consumer sales.
- Supplemental health margins were partially offset by a handful of large claims on older policies, though viewed as isolated events.
- The expense ratio of 18.4% is viewed as a timing difference and is expected to normalize over the remainder of the year.
Price
$54.07 −1.17% · −$0.64
Performance +38.8% 1Y
1Y: $38.96 on 17 Oct 2025 → $54.07. High $56.75 (4 Sept 2026), low $38.96 (17 Oct 2025).
- Previous close
- $54.71
- 52-week range
- $39.5 – $56.75
- One year
- +36.89%
Overview
- Symbol
- CNO
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
10 of 11 judged targets kept · 17 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Exit of the Worksite fee services business | substantially complete in the first half of 2026 | Sep 2025 | Ghosted | |
| Full-year effective tax rate | approximately 22.5% | Dec 2025 | we are lowering our effective tax rate assumption to approximately 21.5% | Revised Up |
| Medicare Supplement rate filings effective 1 January 2026 | average requested rate increase in the 10% range | Jun 2025 | the closed block with a January 1, '26 effective date asking for an increase of 10.5%, and we received approvals for 10.2% | Achieved |
Claimed
- Operating earnings per diluted share up 45% in Q2 and 43% year-to-date, excluding significant items.
- 16th consecutive quarter of sales growth and 14th consecutive quarter of producing agent count growth.
- Full year operating EPS guidance raised to a range of $4.60 to $4.80, an 8% increase at the midpoint.
- Total new annualized premiums (NAP) up 7%, with multiple sales records set.
- Annuity collected premiums reached a new record of $536 million, up 3%, and client assets up 24% to a new record.
Qualified
- Consumer Life NAP was down 9% for the quarter against a strong comparable, primarily driven by lower direct-to-consumer sales.
- Supplemental health margins were partially offset by a handful of large claims on older policies, though viewed as isolated events.
- The expense ratio of 18.4% is viewed as a timing difference and is expected to normalize over the remainder of the year.
The full ledger
Open CNO Financial Group, Inc.’s full ledger
A free account opens 5 company ledgers a month. All 28 tracked commitments, with each call’s wording and source.
Call summaries
Every analysed call
CNO Financial Group earnings calls (CNO)
Financials
What the filings say
Net profit, year on year: +37% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,130 | 1,097 | 1,004 | 1,152 | 1,189 | 1,143 | 1,030 | 1,285 |
| Operating profit | 154 | 174 | 105 | 112 | 163 | 174 | 130 | 151 |
| Operating margin | 13.6% | 15.8% | 10.4% | 9.8% | 13.7% | 15.2% | 12.6% | 11.8% |
| Interest | 68 | 62 | 62 | 59 | 57 | 53 | 51 | 55 |
| Profit before tax | 11 | 232 | 28 | 118 | 36 | 111 | 48 | 160 |
| Tax rate | 15.4% | 19.1% | 22.7% | 22.2% | 77.9% | 3.0% | 22.1% | 21.2% |
| Net profit | 9 | 183 | 22 | 92 | 23 | 93 | 38 | 126 |
| EPS ($ per share) | 0.09 | 1.78 | 0.21 | 0.93 | 0.24 | 0.98 | 0.40 | 1.35 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 197 | 536 | 752 | 1,127 | 1,691 | 1,900 | 2,253 | 2,416 |
| Total liabilities | 28,069 | 28,954 | 29,856 | 30,945 | 31,364 | 32,812 | 35,334 | 36,152 |
| Total assets | 31,440 | 33,631 | 35,340 | 36,204 | 33,133 | 35,027 | 37,849 | 38,791 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 318 | 697 | 736 | 598 | 495 | 583 | 628 | 676 |
| Cash from investing | -526 | -556 | -608 | -1,526 | -1,781 | -872 | -1,489 | -1,667 |
| Cash from financing | 107 | -143 | 210 | 668 | 1,199 | 534 | 1,970 | -23 |
| Net cash flow | -101 | -2 | 337 | -260 | -87 | 244 | 1,109 | -1,014 |
Insider filings
113 filings between Nov 10, 2025 and Sep 16, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$21.82M
34 sales by 9 insiders
97% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 32
- Award — granted as compensation
- 13
- Option exercise — converted options into shares
- 30
- Tax withheld — shares kept back by the company to cover tax
Also filed: 4 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Bhojwani Gary C. | — | $10.82M | Jun 30, 2026 |
| Zimpfer Matthew J. | — | $3.80M | Feb 18, 2026 |
| JOHNSON ERIC R | — | $2.01M | Nov 10, 2025 |
| DeToro Karen J. | — | $1.36M | Sep 2, 2026 |
| TARASI ROCCO F III | — | $1.17M | Jul 1, 2026 |
| Goldberg Scott L. | — | $879.4K | Mar 20, 2026 |
| Linnenbringer Jeanne L. | — | $798.9K | Sep 2, 2026 |
| Franzese Yvonne K | — | $511.6K | Feb 17, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Williams Jeremy D. Chief Actuary | Sale 10b5-1 plan | 1,122 | $62.5K |
| Sep 16, 2026 | Williams Jeremy D. Chief Actuary | Sale 10b5-1 plan | 3,240 | $180.5K |
| Sep 16, 2026 | Williams Jeremy D. Chief Actuary | Option exercise 10b5-1 plan | 3,240 | $75.6K |
| Sep 15, 2026 | Williams Jeremy D. Chief Actuary | Sale 10b5-1 plan | 4,420 | $244.3K |
| Sep 15, 2026 | Williams Jeremy D. Chief Actuary | Option exercise 10b5-1 plan | 4,420 | $93.1K |
| Sep 2, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Sale 10b5-1 plan | 3,919 | $216.0K |
| Sep 2, 2026 | DeToro Karen J. President, Worksite Division | Sale 10b5-1 plan | 5,964 | $328.7K |
| Sep 1, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Sale 10b5-1 plan | 4,060 | $222.2K |
| Sep 1, 2026 | DeToro Karen J. President, Worksite Division | Option exercise 10b5-1 plan | 7,500 | $118.7K |
| Sep 1, 2026 | DeToro Karen J. President, Worksite Division | Sale 10b5-1 plan | 1,836 | $100.5K |
| Sep 1, 2026 | DeToro Karen J. President, Worksite Division | Sale 10b5-1 plan | 7,500 | $410.5K |
| Aug 31, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Sale 10b5-1 plan | 5,010 | $275.5K |
| Aug 31, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Option exercise 10b5-1 plan | 5,010 | $116.9K |
| Aug 31, 2026 | DeToro Karen J. President, Worksite Division | Option exercise 10b5-1 plan | 7,500 | $118.7K |
| Aug 31, 2026 | DeToro Karen J. President, Worksite Division | Sale 10b5-1 plan | 1,874 | $103.0K |
| Aug 31, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Sale 10b5-1 plan | 1,550 | $85.2K |
| Aug 31, 2026 | DeToro Karen J. President, Worksite Division | Sale 10b5-1 plan | 7,500 | $412.3K |
| Jul 1, 2026 | TARASI ROCCO F III Chief Marketing Officer | Sale 10b5-1 plan | 1,891 | $97.0K |
| Jun 30, 2026 | Bhojwani Gary C. Chief Executive Officer | Sale 10b5-1 plan | 44,250 | $2.28M |
| Jun 30, 2026 | Bhojwani Gary C. Chief Executive Officer | Sale 10b5-1 plan | 41,798 | $2.15M |
| Jun 30, 2026 | Bhojwani Gary C. Chief Executive Officer | Option exercise 10b5-1 plan | 44,250 | $931.9K |
| Jun 11, 2026 | TARASI ROCCO F III Chief Marketing Officer | Sale 10b5-1 plan | 5,750 | $287.5K |
| Jun 11, 2026 | TARASI ROCCO F III Chief Marketing Officer | Option exercise 10b5-1 plan | 5,750 | $121.1K |
| Jun 10, 2026 | TARASI ROCCO F III Chief Marketing Officer | Sale 10b5-1 plan | 3,308 | $162.1K |
| Jun 4, 2026 | Goldberg Scott L. President, Consumer Division | Tax withheld | 396 | $18.7K |
| Jun 2, 2026 | TARASI ROCCO F III Chief Marketing Officer | Sale 10b5-1 plan | 4,808 | $226.0K |
| May 12, 2026 | Maurer Dan Director | Award | 6,043 | $279.0K |
| May 12, 2026 | Brown Archie M Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Lee Adrianne Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Foss David B Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Shebik Steven E Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Turner Jessica A Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Ragavan Chetlur S Director | Award | 3,574 | $165.0K |
| May 12, 2026 | Gibson Linda T. Director | Award | 3,574 | $165.0K |
| May 11, 2026 | DeToro Karen J. President, Worksite Division | Gift | 4,400 | $0 |
| Mar 25, 2026 | Koehneman Joel T Chief Accounting Officer | Tax withheld | 202 | $8.2K |
| Mar 25, 2026 | Linnenbringer Jeanne L. Chief Operations Officer | Tax withheld | 1,649 | $67.0K |
| Mar 25, 2026 | Williams Jeremy D. Chief Actuary | Tax withheld | 1,005 | $40.8K |
| Mar 25, 2026 | TARASI ROCCO F III Chief Marketing Officer | Tax withheld | 4,141 | $168.2K |
| Mar 25, 2026 | Mead Michael E. Chief Information Officer | Tax withheld | 1,953 | $79.3K |
| Mar 25, 2026 | DeToro Karen J. President, Worksite Division | Tax withheld | 4,056 | $164.7K |
| Mar 25, 2026 | Franzese Yvonne K Chief Human Resources Officer | Tax withheld | 6,049 | $245.6K |
| Mar 25, 2026 | Bhojwani Gary C. Chief Executive Officer | Tax withheld | 45,746 | $1.86M |
| Mar 25, 2026 | Zimpfer Matthew J. General Counsel | Tax withheld | 7,481 | $303.8K |
| Mar 25, 2026 | McDonough Paul H. Chief Financial Officer | Tax withheld | 13,063 | $530.5K |
| Mar 25, 2026 | JOHNSON ERIC R Chief Investment Officer | Tax withheld | 7,081 | $287.6K |
| Mar 25, 2026 | Goldberg Scott L. President, Consumer Division | Tax withheld | 8,036 | $326.3K |
| Mar 20, 2026 | Goldberg Scott L. President, Consumer Division | Sale 10b5-1 plan | 11,060 | $437.3K |
| Mar 20, 2026 | Goldberg Scott L. President, Consumer Division | Option exercise 10b5-1 plan | 11,060 | $232.9K |
| Mar 19, 2026 | Goldberg Scott L. President, Consumer Division | Option exercise 10b5-1 plan | 11,060 | $232.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for CNO Financial Group, Inc.
Free account. Everything above stays public.
Write why you follow CNO Financial Group, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading